Australia becomes the first country to introduce psychedelic novel therapies to its medical healthcare

Written By Guest User

Starting on July 1st, MDMA and psilocybin will be rescheduled and legalized in Australia for the treatment of PTSD and treatment resistant depression respectively, making Australia the first country in the world to officially recognize and regulate the medical use of these psychedelic drugs. The announcement was made on February 3rd by the Australian government’s Therapeutic Goods Administration.

Guest User
Previous

The Therapeutic Potential of Psychedelics: The European Regulatory Perspective
Next

Rapid and durable response demonstrated in the first placebo-controlled study of DMT for depression